3-溴-5-氯噻酚-2-磺酰氯 | 175205-72-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 中文名称: 3-溴-5-氯噻酚-2-磺酰氯
• 英文名称: 3-Bromo-5-chloro-thiophene-2-sulfonyl chloride
• 英文别名: 3-bromo-5-chlorothiophene-2-sulfonyl chloride
• CAS: 175205-72-8
• 化学式: C₄HBrCl₂O₂S₂
• 分子量: 295.993
• InChiKey: IJWGXKAPAGXFRO-UHFFFAOYSA-N

物化性质

• 熔点：
  34-36°C
• 沸点：
  346.7±42.0 °C(Predicted)
• 密度：
  2.059±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  70.8
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险等级：
  MOISTURE SENSITIVE, CORROSIVE
• 危险品标志：
  Xi,C
• 危险类别码：
  R34
• 危险品运输编号：
  UN 3261
• 海关编码：
  2934999090
• 安全说明：
  S26,S36/37/39,S45

SDS

Name:	3-Bromo-5-chlorothiophene-2-sulfonyl chloride 95+% Material Safety Data Sheet
Synonym:
CAS:	175205-72-8

Section 1 - Chemical Product MSDS Name:3-Bromo-5-chlorothiophene-2-sulfonyl chloride 95+% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
175205-72-8	3-Bromo-5-chlorothiophene-2-sulfonyl c	95+%	unlisted

Hazard Symbols: C
Risk Phrases: 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.Moisture sensitive.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area. Store under nitrogen.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 175205-72-8: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 34 - 36 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C4HBrCl2O2S2
Molecular Weight: 296

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials, exposure to moist air or water.
Incompatibilities with Other Materials:
Oxidizing agents, amines.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, carbon monoxide, oxides of sulfur, carbon dioxide, hydrogen bromide, bromine.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 175205-72-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-Bromo-5-chlorothiophene-2-sulfonyl chloride - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.*
Hazard Class: 8
UN Number: 3261
Packing Group: III
IMO
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 175205-72-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 175205-72-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 175205-72-8 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-溴-5-氯噻酚-2-磺酰氯 、 1-(2-氨基乙基)-2-甲基-5-硝基咪唑 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 3-bromo-5-chloro-N-[2-(2-methyl-5-nitroimidazol-1-yl)ethyl]thiophene-2-sulfonamide
  参考文献：
  名称：

  Metronidazole derivatives as antiparasitic agents

  摘要：

  公开号：

  EP2085394B1
• 作为产物：
  描述：

  4-溴-2-氯噻吩 生成 3-溴-5-氯噻酚-2-磺酰氯
  参考文献：
  名称：

  [EN] NOVEL PROCESS
  [FR] NOUVEAU PROCEDE

  摘要：

  本发明涉及制备药物活性的融合型1,2,4-噻二嗪衍生物的新工艺，其通式为（I），如描述中所定义，以及其中间体。

  公开号：

  WO2001002410A1

文献信息

• Sulfonamides
  申请人：Galley Guido

  公开号：US20060014945A1

  公开（公告）日：2006-01-19

  The invention relates to compounds of the general formula in which R 1 , R 2 , R3, R 4 , R 2′ , R3′, R 4′ , R 5 , and X is —CHR— are as defined in the specification. The invention also provides pharmaceutically acceptable acid addition salts, optically pure enantiomers, racemates and diastereomeric mixtures of such compounds. The invention further provides methods for the treatment of Alzheimer's disease or common cancers.

  该发明涉及一般式化合物，其中R1、R2、R3、R4、R2'、R3'、R4'、R5和X为规范中定义的—CHR—。该发明还提供药学上可接受的酸盐加合物，光学纯对映体，外消旋体和这类化合物的二对映异构体混合物。该发明还提供治疗阿尔茨海默病或常见癌症的方法。
• 11B-HSD1 inhibitors for the treatment of diabetes
  申请人：Amrien Kurt

  公开号：US20050288308A1

  公开（公告）日：2005-12-29

  Compounds of the formula (I): as well as pharmaceutically acceptable salts and esters thereof, wherein R 1 to R 5 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.

  化合物的公式（I）： 以及其药学上可接受的盐和酯，其中R1至R5具有权利要求1中给定的含义，可以用于制成药物组合物。
• Heterocyclic sulfonamide inhibitors of beta amyloid production
  申请人：ArQule

  公开号：US20020183361A1

  公开（公告）日：2002-12-05

  Compounds of Formula (I), 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , T, W, X, Y and Z are as defined herein are provided, together with pharmaceutically acceptable salt, hydrates and/or prodrugs thereof. Methods of using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's Disease and Down's syndrome are described

  提供了符合以下定义的化合物（I）的化合物，其中R1、R2、R3、R4、R5、R6、T、W、X、Y和Z的定义如下，以及其药用盐、水合物和/或前药。描述了使用这些化合物抑制β淀粉样蛋白产生以及治疗阿尔茨海默病和唐氏综合征的方法。
• Synthesis, in vitro Antiproliferative and Anti-HIV Activity of New Derivatives of 2-Piperazino-1,3-benzo[d]thiazoles
  作者：Yaseen A. Al-Soud、Haitham H. Al-Sa’doni、Sadeekah O. W. Saber、Reem H. M. Al-Shaneek、Najim A. Al-Masoudi、P. La Colla

  DOI：10.1515/znb-2010-1113

  日期：2010.11.1

  }-(het)arenecarboxamides 4a - l, sulfonamide derivatives 8a - i as well as benzothiazole-containing N1-(2-oxoethyl)-N1-arylthioureas 9a - c have been synthesized. Compounds 4a - l and 9a were evaluated, in vitro, for their antiproliferative activity against a large panel of human tumor-derived cell lines. Compounds 4l and 9a were the most potent analogs in this series, showing remarkable effects on

  一系列 N-2-oxo-2-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]}-(het)arenecarboxamides 4a - l、磺酰胺衍生物 8a - i 以及已合成含苯并噻唑的 N1-(2-氧乙基)-N1-芳基硫脲 9a-c。体外评价化合物4a-1和9a对一大组人肿瘤衍生细胞系的抗增殖活性。化合物4l和9a是该系列中最有效的类似物，对人脾B淋巴细胞样细胞（WIL-2NS）和人急性B淋巴细胞白血病（CCRF-SB）细胞系（4l：CC50 = 5.1和7.3）显示出显着影响分别为 μM）和化合物 5 对抗 CCRF-SB 细胞系，CC50 = 2.3 μM。这些化合物是进一步开发的主要候选物。化合物 6 - 7a - i 被筛选为抗 HIV-1 和 HIV-2 的抑制剂，没有发现任何活性。
• BISARYLSULFONAMIDES USEFUL IN THE TREATMENT OF INFLAMMATION AND CANCER
  申请人：Kancera AB

  公开号：US20150025068A1

  公开（公告）日：2015-01-22

  A compound of formula (I), useful for the treatment of cancer, inflammation and inflammatory disorders, and a pharmaceutical composition containing the compound.

  公式（I）的化合物，用于治疗癌症、炎症和炎症性疾病，以及含有该化合物的药物组合物。